Cyclin E low-molecular-weight isoform as a predictor of breast cancer in Japanese women.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International surgery

• Publication date

  2011-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.9738/1400.1PMID 22216704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic relevance of cyclin E expression in operable breast cancer.

  2009cited by this paper
• Lifetime and age-conditional probabilities of developing or dying of cancer in Japan.

  2008cited by this paper
• American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

  2007cited by this paper
• Cyclin E Overexpression Reduces Infiltrative Growth in Breast Cancer: Yet Another Link Between Proliferation Control and Tumor Invasion

  2006cited by this paper
• Problems in histological grading of malignancy and its clinical significance in patients with operable Breast Cancer

  2006cited by this paper
• Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries.

  2006cited by this paper
• Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node‐negative breast cancer

  2003cited by this paper
• Expression of cyclins E, A, and B, and prognosis in lymph node‐negative breast cancer

  2003cited by this paper
• Cyclin E in breast cancer.

  2003cited by this paper
• Cyclin E in breast cancer.

  2003cited by this paper
• Expert Commentary.

  2002cited by this paper
• Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest

  2002cited by this paper
• Cyclin E and survival in patients with breast cancer.

  2002cited by this paper
• Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications.

  2001cited by this paper
• Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.

  2001cited by this paper
• Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms

  2001cited by this paper
• Activation of Cyclin E-Dependent Kinase Activity in Colorectal Cancer

  2001cited by this paper
• Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer.

  2001cited by this paper
• Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients.

  2000cited by this paper
• Evaluation of histopathological criteria for identifying nodenegative breast cancer witn high risk of early recurrence in the nsas-bc protocol study

  2000cited by this paper
• Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer.

  1999cited by this paper
• Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

  1998cited by this paper
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• The role of cyclin E in cell proliferation, development and cancer.

  1997cited by this paper
• Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status.

  1996cited by this paper
• Deregulation of cyclin E in breast cancer.

  1995cited by this paper
• Redundant cyclin overexpression and gene amplification in breast cancer cells.

  1993cited by this paper
• Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

  1992cited by this paper
• Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

  1992cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Tumor grade as a prognostic factor in primary breast cancer.

  1989cited by this paper
• The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.

  1987cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Prognostic and Clinicopathological Value of Cyclin E Expression in Breast Cancer: A Meta-Analysis

  2021cites this paper
• TARGETING AUTOPHAGY TO IMPROVE EFFICACY OF CDK4/6 INHIBITION IN BREAST CANCER

  2017cites this paper
• Targeting the Cell Cycle in Breast Cancer

  2016cites this paper
• Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

  2016cites this paper
• Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

  2016cites this paper
• Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer

  2016cites this paper
• Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.

  2016cites this paper
• Cytoplasmic Cyclin E and Phospho e Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer

  year unknowncites this paper